What does it take to pioneer groundbreaking T-cell immunotherapies and vaccines for infectious diseases and cancer? Join us for this episode of BioTalk, where we sit down with Bill Enright, a seasoned biotech executive with a remarkable track record spanning over three decades. Bill brings a wealth of experience in building and financing both privately held and publicly traded companies, making his mark in various roles within the life science/biotech industry.
Bill offers a compelling update in this installment since his previous appearance on BioTalk. Learn about the intriguing journey that led Vaccitech, a clinical-stage T cell immunotherapy and vaccine company, to select Germantown, MD, within the thriving BioHealth Capital Region, for its new site. Delve into the intricacies of their pioneering platform, which harnesses the power of immunotherapy Chimpanzee Adenovirus Oxford (ChAdOx) and Modified Vaccinia Ankara (MVA) to elicit robust T cell responses and antibodies against infectious agents and tumors.
Get an insider's perspective as Bill provides clinical updates on their groundbreaking work, discussing major milestones in critical areas like HBV, HPV, PCA, and VTB, among others. Explore Vaccitech's path forward as Bill sheds light on their next significant milestones and strategic plans to expand their presence within the United States.
Don't miss this exclusive conversation with Bill Enright as he shares insights into the dynamic world of immunotherapy and Vaccitech's mission to transform the disease treatment and prevention landscape.
Advancing Biotech: Insights from Michael J. Tarlov, Chief of the Biomolecular Measurement Division at NIST
Building Baltimore's Future: Kory Bailey and the UpSurge Vision
John Sackett - Execuitve Vice President & COO, Adventist Healthcare
Empowering Change: Lance Kawaguchi's Journey with the Cure Brain Cancer Foundation
Nanochon's Orthopedic Revolution: A New Era in Cartilage Restoration
Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias
Navigating the AI Wave: Dr. Juergen Klenk Explores AI's Reality in the BioHealth Industry
Pioneering Solutions: Dr. Nehal Mehta's Quest to Combat Chronic Diseases at Mobius Scientific
Investing in BioHealth: Blackbird Labs Vision with CEO Matt Tremblay
Breaking Barriers in Enteral Nutrition: Luminoah's Innovative MedTech with Neal Piper
Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)
Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)
Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies
Navigating the Future of Autoimmune Medicine: A Conversation with Dr. Theresa Podrebarac, Senior Vice President, Clinical Development at Horizon Therapeutics
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Nurturing Tomorrow's STEM Leaders: A Conversation with Dr. Judy Staveley, Biotechnologist and STEM Advocate
How the BioHealth Capital Region Became a Top 3 BioPharma Cluster: Insights from Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News
Navigating Growth and Collaboration in Life Sciences: A Conversation with Brad L. Stewart, SVP of Business Development, MCEDC
Building Better Medicine, and Transformative Partnerships: Insights from Joy Polefrone, Ph.D. on BioTalk
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money